Market Report · May 18, 2026
Report Feature
The future of the immunoassay market looks promising with opportunities in hospitals, blood banks, clinical laboratories, pharmaceutical and biotech companies, and academic research centers. The global immunoassay market is expected to grow with a CAGR of 5%-7% from 2020 to 2025. The major drivers for this market are rising prevalence of chronic and infectious diseases, technological advancements in POC testing products, and growing patient awareness of POC testing.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global immunoassay market report, please download the report brochure.
In this market, reagents & kits is the largest product of immunoassay, whereas infectious disease is the largest application. Growth in various segments of the immunoassay market are given below:
The study includes trends and forecast for the global immunoassay market by product and service, technology, application, platform, specimen, end user, and region as follows:
By Product and Service [Value ($ Million) shipment analysis for 2014 – 2025]:
- Reagents & Kits
- Analyzers
- Software
By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
- ELISA
- First-generation
- Second-generation
- Third-generation
- Fourth-generation & Above
- Rapid Tests
- Western Blotting
- ELISPOT
- Immuno-PCR
- Other Technologies
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
- Infectious Diseases
- Endocrinology
- Oncology
- Bone & Mineral Disorders
- Cardiology
- Hematology & Blood Screening
- Autoimmune Disorders
- Toxicology
- Neonatal Screening
- Other Applications
By Platform [Value ($ Million) shipment analysis for 2014 – 2025]:
- Chemiluminescence Immunoassays (CLIAs)
- Fluorescence Immunoassays (FIAs)
- Colorimetric Immunoassays (CIs)
- Radioimmunoassays (RIAs)
- Other Platforms
By Specimen [Value ($ Million) shipment analysis for 2014 – 2025]:
- Blood
- Saliva
- Urine
- Other Specimens
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
- Hospitals
- Blood Banks
- Clinical Laboratories
- Pharmaceutical and Biotech Companies
- Academic Research Centers
- Others
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
-
North America
- United States
- Canada
- Mexico
-
Europe
- United Kingdom
- Spain
- Germany
- France
-
Asia Pacific
- China
- India
- Japan
-
The Rest of the World
- Brazil
Some of the immunoassay companies profiled in this report include Roche, Abbott Laboratories, Siemens, Danaher Corporation, Sysmex Corporation, BioMérieux, Ortho Clinical Diagnostics, DiaSorin, QIAGEN, and Thermo Fisher Scientific.
Lucintel forecasts that reagents & kits will remain the largest product and service segment over the forecast period due to the requirement of repeat purchases of kits and reagents, increasing number of immunoassay tests, and rising incidence of chronic and infectious diseases.
Within this market, hospitals will remain the largest end user segment over the forecast period due to increase in prevalence of chronic diseases, such as cancer, infectious diseases, and autoimmune diseases.
North America will remain the largest region over the forecast period due to increasing incidence of chronic diseases and improved healthcare infrastructure in the region.
|
Features of the Global Immunoassay Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global immunoassay market by product & service (reagents & kits, analyzers, and software), technology (ELISA, first-generation, second-generation, third-generation, fourth-generation & above, rapid tests, western blotting, ELISPOT, immuno-PCR, and other technologies), application (infectious diseases, endocrinology, oncology,bone & mineral disorders, cardiology, hematology & blood screening, autoimmune disorders, toxicology, neonatal screening, and other applications), platform (chemiluminescence immunoassays (CLIAs), fluorescence immunoassays (FIAs), colorimetric immunoassays (CIs), radioimmunoassays (RIAs), and other platforms), specimen (blood, saliva, urine, and other specimens), end user (hospitals, blood banks, clinical laboratories, pharmaceutical and biotech companies, academic research centers, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global immunoassay market? Q.5 What are the business risks and threats to the global immunoassay market? Q.6 What are emerging trends in this immunoassay market and the reasons behind them? Q.7 What are some changing demands of customers in this immunoassay market? Q.8 What are the new developments in this immunoassay market? Which companies are leading these developments? Q.9 Who are the major players in this immunoassay market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this immunoassay market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global immunoassay market? |
Report Scope
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | Product & Service (Reagents & Kits, Analyzers, and Software), Technology (ELISA, First-Generation, Second-Generation, Third-Generation, Fourth-Generation & Above, Rapid Tests, Western Blotting, ELISPOT, Immuno-PCR, and Other Technologies), Platform (Chemiluminescence Immunoassays (CLIAs), Fluorescence Immunoassays (FIAs), Colorimetric Immunoassays (CIs), Radioimmunoassays (RIAs), and Other Platforms), Specimen (Blood, Saliva, Urine, and Other Specimens), Application (Infectious Diseases, Endocrinology, Oncology, Bone & Mineral Disorders, Cardiology, Hematology & Blood Screening, Autoimmune Disorders, Toxicology, Neonatal Screening, and Other Applications), and End User (Hospitals, Blood Banks, Clinical Laboratories, Pharmaceutical And Biotech Companies, Academic Research Centers, and Others) |
Regional Scope |
North America (USA, Mexico, and Canada), Europe (United Kimgdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
1. Executive Summary
7.2 Emerging Trends in the Global Immunoassay Market
4.1 Global Immunoassay Market by Region
4.2.1 Market by Product & Service: Reagents & Kits, Analyzers, and Software
4.2.2 Market by Technology: ELISA, First-Generation, Second-Generation, Third-Generation, Fourth-Generation & Above, Rapid Tests, Western Blotting, ELISPOT, Immuno-PCR, and Other Technologies
4.2.3 Market by Application: Infectious Diseases, Endocrinology, Oncology, Bone & Mineral Disorders, Cardiology, Hematology & Blood Screening, Autoimmune Disorders, Toxicology, Neonatal Screening, and Other Applications
4.2.4 Market by Platform: Chemiluminescence Immunoassays (CLIAs), Fluorescence Immunoassays (FIAs), Colorimetric Immunoassays (CIs), Radioimmunoassays (RIAs), and Other Platforms
4.2.5 Market by Specimen: Blood, Saliva, Urine, and Other Specimens
4.2.6 Market by End User: Hospitals, Blood Banks, Clinical Laboratories, Pharmaceutical And Biotech Companies, Academic Research Centers, and Others
4.2.7 The United States Immunoassay Market
4.2.8 The Canadian Immunoassay Market
4.2.9 The Mexican Immunoassay Market
4.3.1 Market by Product & Service: Reagents & Kits, Analyzers, and Software
4.3.2 Market by Technology: ELISA, First-Generation, Second-Generation, Third-Generation, Fourth-Generation & Above, Rapid Tests, Western Blotting, ELISPOT, Immuno-PCR, and Other Technologies
4.3.3 Market by Application: Infectious Diseases, Endocrinology, Oncology, Bone & Mineral Disorders, Cardiology, Hematology & Blood Screening, Autoimmune Disorders, Toxicology, Neonatal Screening, and Other Applications
4.3.4 Market by Platform: Chemiluminescence Immunoassays (CLIAs), Fluorescence Immunoassays (FIAs), Colorimetric Immunoassays (CIs), Radioimmunoassays (RIAs), and Other Platforms
4.3.5 Market by Specimen: Blood, Saliva, Urine, and Other Specimens
4.3.6 Market by End User: Hospitals, Blood Banks, Clinical Laboratories, Pharmaceutical And Biotech Companies, Academic Research Centers, and Others
4.3.7 The United Kingdom Immunoassay Market
4.3.8 The Spanish Immunoassay Market
4.3.9 The German Immunoassay Market
4.3.10 The French Immunoassay Market
4.4.1 Market by Product & Service: Reagents & Kits, Analyzers, and Software
4.4.2 Market by Technology: ELISA, First-Generation, Second-Generation, Third-Generation, Fourth-Generation & Above, Rapid Tests, Western Blotting, ELISPOT, Immuno-PCR, and Other Technologies
4.4.3 Market by Application: Infectious Diseases, Endocrinology, Oncology, Bone & Mineral Disorders, Cardiology, Hematology & Blood Screening, Autoimmune Disorders, Toxicology, Neonatal Screening, and Other Applications
4.4.4 Market by Platform: Chemiluminescence Immunoassays (CLIAs), Fluorescence Immunoassays (FIAs), Colorimetric Immunoassays (CIs), Radioimmunoassays (RIAs), and Other Platforms
4.4.5 Market by Specimen: Blood, Saliva, Urine, and Other Specimens
4.4.6 Market by End User: Hospitals, Blood Banks, Clinical Laboratories, Pharmaceutical And Biotech Companies, Academic Research Centers, and Others
4.4.7 The Chinese Immunoassay Market
4.4.8 The Indian Immunoassay Market
4.4.9 The Japanese Immunoassay Market
4.5.1 Market by Product & Service: Reagents & Kits, Analyzers, and Software
4.5.2 Market by Technology: ELISA, First-Generation, Second-Generation, Third-Generation, Fourth-Generation & Above, Rapid Tests, Western Blotting, ELISPOT, Immuno-PCR, and Other Technologies
4.5.3 Market by Application: Infectious Diseases, Endocrinology, Oncology, Bone & Mineral Disorders, Cardiology, Hematology & Blood Screening, Autoimmune Disorders, Toxicology, Neonatal Screening, and Other Applications
4.5.4 Market by Platform: Chemiluminescence Immunoassays (CLIAs), Fluorescence Immunoassays (FIAs), Colorimetric Immunoassays (CIs), Radioimmunoassays (RIAs), and Other Platforms
4.5.5 Market by Specimen: Blood, Saliva, Urine, and Other Specimens
4.5.6 Market by End User: Hospitals, Blood Banks, Clinical Laboratories, Pharmaceutical And Biotech Companies, Academic Research Centers, and Others
4.5.7 Brazilian Immunoassay Market
7.1.1 Growth Opportunities for the Global Immunoassay Market by Product and Service
7.1.2 Growth Opportunities for the Global Immunoassay Market by Technology
7.1.3 Growth Opportunities for the Global Immunoassay Market by Application
7.1.4 Growth Opportunities for the Global Immunoassay Market by Platform
7.1.5 Growth Opportunities for the Global Immunoassay Market by Specimen
7.1.6 Growth Opportunities for the Global Immunoassay Market by End User
7.1.7 Growth Opportunities for the Global Immunoassay Market by Region
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
